000 | 01960 a2200529 4500 | ||
---|---|---|---|
005 | 20250513112336.0 | ||
264 | 0 | _c19970311 | |
008 | 199703s 0 0 eng d | ||
022 | _a0962-8479 | ||
024 | 7 |
_a10.1016/s0962-8479(96)90049-0 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aWallis, R S | |
245 | 0 | 0 |
_aImmune activation, allergic drug toxicity and mortality in HIV-positive tuberculosis. _h[electronic resource] |
260 |
_bTubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease _cDec 1996 |
||
300 |
_a516-23 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
650 | 0 | 4 |
_aAIDS-Related Opportunistic Infections _xcomplications |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aAntitubercular Agents _xadverse effects |
650 | 0 | 4 |
_aBiopterins _xanalogs & derivatives |
650 | 0 | 4 | _aCohort Studies |
650 | 0 | 4 | _aDrug Therapy, Combination |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHIV-1 |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMultivariate Analysis |
650 | 0 | 4 | _aNeopterin |
650 | 0 | 4 | _aRandom Allocation |
650 | 0 | 4 |
_aReceptors, Interleukin-2 _xblood |
650 | 0 | 4 |
_aReceptors, Tumor Necrosis Factor _xblood |
650 | 0 | 4 |
_aSkin Diseases _xchemically induced |
650 | 0 | 4 | _aSurvival Analysis |
650 | 0 | 4 | _aTuberculin Test |
650 | 0 | 4 |
_aTuberculosis _xcomplications |
650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xanalysis |
650 | 0 | 4 |
_abeta 2-Microglobulin _xanalysis |
700 | 1 | _aHelfand, M S | |
700 | 1 | _aWhalen, C C | |
700 | 1 | _aJohnson, J L | |
700 | 1 | _aMugerwa, R D | |
700 | 1 | _aVjecha, M | |
700 | 1 | _aOkwera, A | |
700 | 1 | _aEllner, J J | |
773 | 0 |
_tTubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease _gvol. 77 _gno. 6 _gp. 516-23 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0962-8479(96)90049-0 _zAvailable from publisher's website |
999 |
_c9028160 _d9028160 |